HX9428
/ Fujian Haixi New Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 23, 2025
Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)
(clinicaltrials.gov)
- P1/2 | N=198 | Recruiting | Sponsor: Fujian Haixi Pharmaceuticals Co., Ltd.
New P1/2 trial • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration
1 to 1
Of
1
Go to page
1